Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Sex influences on cholinesterase inhibitor treatment in elderly individuals with Alzheimer's disease.

The American journal of geriatric pharmacotherapy - 1 Sept 2006

Haywood Wendy M, Mukaetova-Ladinska Elizabeta B

Abstract excerpt

BACKGROUND: The second generation of cholinesterase inhibitors (ChEIs) is approved in the United Kingdom for the treatment of mild to moderate Alzheimer's disease (AD). The UK National Institute of Clinical Excellence has raised questions, however, about whether ChEIs are cost-effective for the treatment of dementia. To address these concerns, it is important to identify factors that predict which patients may...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Alzheimer Disease
Share to Apolipoproteins E

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cholinesterase Inhibitors

Share to Clinical Trials as Topic

Share to Genotype

Share to Sex Factors

Source

Identifiers

PMID: 17062329
DOI: 10.1016/j.amjopharm.2006.09.009

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Sex influences on cholinesterase inhibitor treatment in elderly individuals with Alzheimer's disease.PMID 17062329Read ↗

Sex and ESR1 genotype may influence the response to treatment with donepezil and rivastigmine in patients with Alzheimer's disease.Semantic proximity Read ↗

Effect of gender and apolipoprotein E genotype on response to anticholinesterase therapy in Alzheimer's disease.Semantic proximity Read ↗

Progression from mild cognitive impairment to Alzheimer's disease: effects of sex, butyrylcholinesterase genotype, and rivastigmine treatment.Semantic proximity Read ↗

Treatment outcome of tacrine therapy depends on apolipoprotein genotype and gender of the subjects with Alzheimer's disease.Semantic proximity Read ↗

Pharmacogenetic considerations when prescribing cholinesterase inhibitors for the treatment of Alzheimer's disease.Semantic proximity Read ↗

Combined tacrine and estrogen replacement therapy in patients with Alzheimer's disease.Semantic proximity Read ↗

Serum cholesterol levels modulate long-term efficacy of cholinesterase inhibitors in Alzheimer disease.Semantic proximity Read ↗

BCHE and CYP2D6 genetic variation in Alzheimer's disease patients treated with cholinesterase inhibitors.Semantic proximity Read ↗

Apolipoprotein E genotype and gender influence response to tacrine therapy.Semantic proximity Read ↗

Hormone replacement therapy in postmenopausal women with Alzheimer's disease: a randomized, prospective study.Semantic proximity Read ↗

Sex-Dependent Effects of Rivastigmine on Melatonin Receptors in Aged RatsSemantic proximity Read ↗

Effect of butyrylcholinesterase genotype on the response to rivastigmine or donepezil in younger patients with Alzheimer's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.